NEUROCRINE BIOSCIENCES INC (NBIX)
Biological Products, (No Diagnostic Substances) · Healthcare · $15.7B
Intrinsic Value (Consensus)
$65.68
Current Price
$156.42
Margin of Safety
-58%
58% Above Intrinsic Value
Value: $66
Price: $156
Valuation Model Estimates
Current Price: $156.42
DCF (Discounted Cash Flow)
$349.01
Graham Number
$58.29
Earnings Power Value
$45.34
Relative Value (P/E)
$93.40
Dividend Discount Model
Not applicable
—
Consensus Value
$65.68
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
64
Profitability
18/25
Strength
17/25
Valuation
7/25
Growth
22/25
Financial Health Signals
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $4.67
- EPS (Forward)
- $5.60
- Book Value
- $32.34
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 14.7%
- Debt/Equity
- —
- Revenue Growth
- 21.4%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance